Concurrent and Close Temporal Administration of Lithium and ECT

Area of Science:

• Neuroscience
• Psychiatry
• Clinical Pharmacology

Background:

• Electroconvulsive therapy (ECT) is a potent treatment for severe mental health conditions.
• Lithium (Li) is a mood stabilizer often used in conjunction with other psychiatric treatments.
• The safety and efficacy of combined ECT and Li treatment require careful consideration due to potential interactions.

Purpose of the Study:

• To investigate the clinical effects of concurrent and close temporal administration of electroconvulsive therapy (ECT) and lithium (Li).
• To compare ECT-related complications, total length of hospital stay (LOS), and post-ECT hospital stay across different ECT-Li administration timings.

Main Methods:

• Retrospective chart review of patients undergoing ECT.
• Comparison of three patient groups: concurrent ECT-Li, Li within 24h pre-ECT or 48h post-ECT, and ECT without Li.
• Analysis of ECT-related complications, total LOS, and post-ECT LOS.

Main Results:

• Prolonged or severe post-ECT confusion was significantly associated with close temporal administration of Li relative to the ECT course.
• No significant differences were found in the number of complications or total LOS between groups.
• Post-ECT LOS was significantly longer in patients receiving Li in close temporal association with ECT.

Conclusions:

• Caution is advised when combining electroconvulsive therapy (ECT) and lithium (Li), particularly regarding the timing of administration.
• Close temporal proximity of Li to ECT is linked to increased risk of prolonged post-ECT confusion and extended hospital stays.
• Further research may be warranted to optimize the combined use of these treatment modalities for patient safety.